Qilian International Holding Group Ltd
NASDAQ:BGM

Watchlist Manager
Qilian International Holding Group Ltd Logo
Qilian International Holding Group Ltd
NASDAQ:BGM
Watchlist
Price: 3.975 USD 2.45% Market Closed
Market Cap: 645.8m USD

Relative Value

There is not enough data to reliably calculate the relative value of BGM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BGM Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
1.1
Median 5Y
2.1
Industry
2.6
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
96.1
Industry
21.4
vs History
vs Industry
Median 3Y
91.6
Median 5Y
84.8
Industry
16.4
vs History
vs Industry
Median 3Y
-17.5
Median 5Y
-17.5
Industry
22.8
vs History
vs Industry
Median 3Y
1.2
Median 5Y
2.6
Industry
2.2
vs History
vs Industry
Median 3Y
0.6
Median 5Y
2
Industry
2.9
vs History
vs Industry
Median 3Y
16.8
Median 5Y
21.5
Industry
5.5
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
44.8
Industry
13
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
70.8
Industry
16.5
vs History
vs Industry
Median 3Y
27.9
Median 5Y
71.8
Industry
15.6
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-8.3
Industry
18.7
vs History
vs Industry
Median 3Y
1.2
Median 5Y
2.6
Industry
1.9

Multiples Across Competitors

BGM Competitors Multiples
Qilian International Holding Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Qilian International Holding Group Ltd
NASDAQ:BGM
51.3m USD 1.1 -6.6 -20 -11.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.7 38 40.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.5B USD 5.4 19.8 16.2 21.1
CH
Roche Holding AG
SIX:ROG
268.8B CHF 4.4 28.5 12.1 14.2
UK
AstraZeneca PLC
LSE:AZN
219.6B GBP 5.1 31.5 108.7 159.1
US
Merck & Co Inc
NYSE:MRK
277.5B USD 4.3 14.6 10.3 12.2
CH
Novartis AG
SIX:NOVN
219.4B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.8B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
CN
Qilian International Holding Group Ltd
NASDAQ:BGM
Average P/E: 25.1
Negative Multiple: -6.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
56.7
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.5
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.6
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Qilian International Holding Group Ltd
NASDAQ:BGM
Average EV/EBITDA: 440.1
Negative Multiple: -20
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.1
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Qilian International Holding Group Ltd
NASDAQ:BGM
Average EV/EBIT: 1 883.7
Negative Multiple: -11.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.7
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5